Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.

Citrome L, Jaffe A, Levine J, Allingham B, Robinson J.

Psychiatr Serv. 2004 Sep;55(9):1006-13.

PMID:
15345760
2.

Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.

Lambert BL, Chou CH, Chang KY, Tafesse E, Carson W.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):417-25.

PMID:
15786516
3.

Olanzapine versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Duggan L, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006654. doi: 10.1002/14651858.CD006654.pub2. Review.

4.

An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.

Krzystanek M, Krupka-Matuszczyk I.

Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9. Review.

PMID:
23055416
5.

Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States.

Feldman PD, Hay LK, Deberdt W, Kennedy JS, Hutchins DS, Hay DP, Hardy TA, Hoffmann VP, Hornbuckle K, Breier A.

J Am Med Dir Assoc. 2004 Jan-Feb;5(1):38-46.

PMID:
14706127
6.

Quetiapine versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Schmid F, Hunger H, Schwarz S, Srisurapanont M, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006625. doi: 10.1002/14651858.CD006625.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;11:CD006625.

7.

Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.

Leslie DL, Rosenheck RA.

Am J Psychiatry. 2004 Sep;161(9):1709-11.

PMID:
15337666
8.

Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.

Østbye T, Curtis LH, Masselink LE, Hutchison S, Wright A, Dans PE, Schulman KA, Krishnan RR.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):407-15.

PMID:
15372671
9.

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.

Sernyak MJ, Leslie DL, Alarcon RD, Losonczy MF, Rosenheck R.

Am J Psychiatry. 2002 Apr;159(4):561-6.

PMID:
11925293
11.

Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature.

Cohen D.

Pharmacopsychiatry. 2004 Jan;37(1):1-11. Review.

PMID:
14750042
12.

Risperidone versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD006626. doi: 10.1002/14651858.CD006626.pub2. Review.

13.

[Therapy with antipsychotic drugs as a risk factor for diabetes in schizophrenia: a case-control study].

Rubio G, Gómez-de-la-Cámara A, Ledesma F, Burón JA, Rodríguez-Morales A, Martínez-Junquera G; Grupo Español para el Estudio de la Diabetes en Pacientes Esquizofrénicos.

Med Clin (Barc). 2006 Apr 1;126(12):441-4. Spanish.

PMID:
16620729
14.

Second-generation antipsychotic medications and risk of pneumonia in schizophrenia.

Kuo CJ, Yang SY, Liao YT, Chen WJ, Lee WC, Shau WY, Chang YT, Tsai SY, Chen CC.

Schizophr Bull. 2013 May;39(3):648-57. doi: 10.1093/schbul/sbr202. Epub 2012 Jan 26.

15.

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.

Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Lobos CA, Kissling W, Davis JM, Leucht S.

Schizophr Res. 2010 Nov;123(2-3):225-33. doi: 10.1016/j.schres.2010.07.012. Epub 2010 Aug 7. Review.

16.

Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone.

Manu P, Correll CU, Wampers M, van Winkel R, Yu W, Shiffeldrim D, Kane JM, De Hert M.

Schizophr Res. 2013 Feb;143(2-3):358-62. doi: 10.1016/j.schres.2012.11.016. Epub 2012 Dec 9.

PMID:
23231880
17.

Clozapine versus other atypical antipsychotics for schizophrenia.

Asenjo Lobos C, Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Leucht S.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD006633. doi: 10.1002/14651858.CD006633.pub2. Review.

19.

Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design.

Gianfrancesco F, Pesa J, Wang RH, Nasrallah H.

Am J Health Syst Pharm. 2006 Mar 1;63(5):431-41.

PMID:
16484517
20.
Items per page

Supplemental Content

Write to the Help Desk